RHT — Resonance Health Income Statement
0.000.00%
Last trade - 00:00- AU$16.09m
- AU$16.17m
- AU$8.80m
- 58
- 71
- 23
- 52
Annual income statement for Resonance Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.71 | 3.82 | 3.83 | 4.51 | 8.8 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.66 | 3.38 | 5.58 | 6.06 | 9.47 |
| Operating Profit | -0.949 | 0.432 | -1.74 | -1.55 | -0.665 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.953 | 0.344 | -1.55 | -1.26 | -0.627 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.715 | 0.586 | -1.14 | -0.78 | 0.169 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.715 | 0.586 | -1.14 | -0.78 | 0.169 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.715 | 0.586 | -1.14 | -0.78 | 0.169 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | 0.001 | -0.003 | -0.002 | 0 |